This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked EMX2 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-EMX2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~28.3 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Cerebellum (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | — | |
| Caveat | — | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 2 isoform(s) |
The A04322-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human lung tissue lysate (catalog A04322-1) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A04322-1 · (A) 1 and (B) 2 μg/mL (catalog A04322-1) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
EMX2 is predicted at 28.3 kDa; its two isoforms could affect migration, but no distinct isoform bands or empirical band size are established.
| Single band near 28.3 kDa | Consistent with the predicted EMX2 mass; confirm identity with antibody controls |
| Two discrete bands at different positions | Could reflect isoforms 1 and 2 if both are expressed and resolve separately |
| Single band away from 28.3 kDa | Could represent an EMX2 isoform, but its identity requires confirmation |
| Faint band in whole-cell lysate | Nuclear localization may make EMX2 easier to detect in an enriched fraction |
| UniProt predicted mass | Places the reference size at 28.3 kDa |
| Alternative splicing | Could produce products with different apparent sizes; separation is unestablished |
| Isoform 1 | Its size relative to isoform 2 is not supplied |
| Isoform 2 | Its size relative to isoform 1 is not supplied |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Nuclear EMX2 may be difficult to detect in an unfractionated sample | Check a nuclear fraction and verify antibody performance |
| Band higher than expected | An isoform is possible, but its migration is not established | Compare with an EMX2-positive control and verify antibody specificity |
| Band lower than expected | An isoform is possible, but its migration is not established | Use an EMX2-positive control and check for sample degradation |
| Multiple bands | Isoforms 1 and 2 may contribute, though distinct bands are not established | Check antibody specificity and compare samples with different EMX2 expression |
| Weak or no signal | Nuclear localization may limit signal in the tested fraction | Enrich nuclei and check lysate loading and antibody performance |
| Fragments below expected size | No cleavage feature is listed to explain fragments | Check sample integrity and confirm band identity with specificity controls |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Cerebellum | GLUC cells - cytoplasm/membrane | Medium | Protein (IHC) | HPA → |
| Endometrium | cells in endometrial stroma | Medium | Protein (IHC) | HPA → |
| Epididymis | glandular cells | Medium | Protein (IHC) | HPA → |
| Fallopian tube | non-ciliated cells | Medium | Protein (IHC) | HPA → |
| Kidney | collecting ducts | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for EMX2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The listed anti-EMX2 antibody has a Western blot image using human lung tissue lysate at 1 and 2 μg/mL. The supplied evidence covers this tested context only.
Which to pick: A04322-1 is the only listed option. It reports human reactivity and includes a Western blot image from human lung tissue lysate; consider your sample and assay conditions when choosing it.